Michael Dershem, aka Dersh, is a seasoned business development entrepreneur primarily in the healthcare and pharma space, has assisted multiple ventures and attracted millions of dollars of capital. Strong technology-transfer background from government and university research to private sector commercialization. Michael began his career over twenty years ago as co-owner of RX Returns, the first reverse distributor ever licensed by the FDA and DEA, which grew to become the largest pharmaceutical returns company in the nation. He later helped form a niche banking company. Dersh was founding CEO of Pharmasset, an Emory University start-up, that raised over $25 million in private equity funding and executed a $30 million research and development agreement with DuPont. Pharmasset subsequently went public and was acquired by Gilead Sciences for $11 Billion. Dersh graduated with a BA in Economics from Dickinson College and holds an MBA.
The availability of innovative technologies affords us the opportunity to chart a more patient-centric, efficient, and secure path to managing and leveraging PHI.